Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Adeline, Durand"'
Autor:
Elizabeth Hughes, Terry McCormack, Christopher Ll Morgan, Adeline Durand, Thomas R Berni, Raquel Lahoz
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Objectives To estimate the 12-month probabilities of major adverse cardiovascular events (MACE) and non-cardiovascular death in patients with atherosclerotic cardiovascular disease (ASCVD) and elevated low-density lipoprotein cholesterol (LDL-C).Desi
Externí odkaz:
https://doaj.org/article/a1884766473846deb467ecc40a7a7f54
Autor:
Jason Lester, Carles Escriu, Sarah Khan, Emma Hudson, Talal Mansy, Andrew Conn, Samuel Chan, Ceri Powell, Juliet Brock, John Conibear, Lauren Nelless, Vaneet Nayar, Xiaohui Zhuo, Adeline Durand, Amerah Amin, Peter Martin, Xinke Zhang, Vivek Pawar
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The treatment landscape for advanced non-small cell lung cancer (aNSCLC) has evolved rapidly since immuno-oncology (IO) therapies were introduced. This study used recent data to assess real-world treatment patterns and clinical ou
Externí odkaz:
https://doaj.org/article/dc0b45bae2d243a6977fe1c09edaddf0
Publikováno v:
Value in Health.
Autor:
Justine Marsolier, Pacôme Prompsy, Adeline Durand, Anne-Marie Lyne, Camille Landragin, Amandine Trouchet, Sabrina Tenreira Bento, Almut Eisele, Sophie Foulon, Léa Baudre, Kevin Grosselin, Mylène Bohec, Sylvain Baulande, Ahmed Dahmani, Laura Sourd, Eric Letouzé, Anne-Vincent Salomon, Elisabetta Marangoni, Leïla Perié, Céline Vallot
Publikováno v:
Nature Genetics
Nature Genetics, 2022, 54, pp.459-468. ⟨10.1038/s41588-022-01047-6⟩
Nature Genetics, 2022, 54, pp.459-468. ⟨10.1038/s41588-022-01047-6⟩
International audience; The persistence of cancer cells resistant to therapy remains a major clinical challenge. In triple-negative breast cancer, resistance to chemotherapy results in the highest recurrence risk among breast cancer subtypes. The dru
Autor:
Anurag Kumar Sinha, Christophe Possoz, Adeline Durand, Jean-Michel Desfontaines, François-Xavier Barre, David R F Leach, Bénédicte Michel
Publikováno v:
PLoS Genetics, Vol 14, Iss 3, p e1007256 (2018)
It was recently reported that the recBC mutants of Escherichia coli, deficient for DNA double-strand break (DSB) repair, have a decreased copy number of their terminus region. We previously showed that this deficit resulted from DNA loss after post-r
Externí odkaz:
https://doaj.org/article/47a0245915e84020b9ce3a42fe5784f1
Autor:
Anurag Kumar Sinha, Adeline Durand, Jean-Michel Desfontaines, Ielyzaveta Iurchenko, Hélène Auger, David R F Leach, François-Xavier Barre, Bénédicte Michel
Publikováno v:
PLoS Genetics, Vol 13, Iss 10, p e1006895 (2017)
Marker frequency analysis of the Escherichia coli recB mutant chromosome has revealed a deficit of DNA in a specific zone of the terminus, centred on the dif/TerC region. Using fluorescence microscopy of a marked chromosomal site, we show that the di
Externí odkaz:
https://doaj.org/article/07ba521df5de432daa3231c15081608d
Autor:
Emma Hudson, Amerah Amin, Jason Francis Lester, Vaneet Nayar, Xiaohui Zhuo, Adeline Durand, Peter Martin, Andrew Conn, Ceri Powell, C. Escriu, Lauren Nelless, Samuel Chan, Xinke Zhang, Vivek Pawar, Talal Mansy, John Conibear, Juliet Brock, Sarah Khan
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background The treatment landscape for advanced non-small cell lung cancer (aNSCLC) has evolved rapidly since immuno-oncology (IO) therapies were introduced. This study used recent data to assess real-world treatment patterns and clinical outcomes in
Autor:
Camille Landragin, Melissa Saichi, Pacôme Prompsy, Adeline Durand, Jérémy Mesple, Amandine Trouchet, Marisa Faraldo, Hélène Salmon, Céline Vallot
SUMMARYDefects in double-strand repair mechanisms - both through germline or somatic inactivation of repair genes - is a hallmark of basal-like breast cancers. In this genetically-unstable context, a recurrent shift in cell identity occurs within the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a574f1f1e69b6cfe525806ea0027c71
https://doi.org/10.1101/2022.06.08.494710
https://doi.org/10.1101/2022.06.08.494710
Publikováno v:
PLoS Genetics, Vol 12, Iss 6, p e1006114 (2016)
Mutants lacking the ψ (HolD) subunit of the Escherichia coli DNA Polymerase III holoenzyme (Pol III HE) have poor viability, but a residual growth allows the isolation of spontaneous suppressor mutations that restore ΔholD mutant viability. Here we
Externí odkaz:
https://doaj.org/article/38581a7c78014bcc9447c393e8cf72d9
Autor:
Daniel Gaertner, Julia Kundin, Neelamegan Esakkiraja, Jasper Berndt, Adeline Durand, Josua Kottke, Stephan Klemme, Guillaume Laplanche, Gunther Eggeler, Gerhard Wilde, Aloke Paul, Ingo Steinbach, Sergiy V. Divinski
Publikováno v:
SSRN Electronic Journal.